Roberto Muga (Robert Muga, R Muga)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 20

Top Topics

Alcohol Use Disorder

High Resolution Mass Spectrometry

Top Venues

Addiction science & clinical practice

Journal of clinical medicine

Alcohol, clinical & experimental research

This page only lists publications with an associated author ORCID identifier.

Publications

Paola Zuluaga, Julia Casado-Carbajo, Anna Hernández-Rubio, Marvin Bueno-Vélez, Carmen García-Martin, Roberto Muga, Daniel Fuster
Vitamin D Deficiency Is Associated with Advanced Liver Fibrosis and Impaired Fasting Glucose in Alcohol Use Disorder. Nutrients 16 (8) (2024)
Paola Zuluaga, Julia Casado-Carbajo, Anna Hernández-Rubio, Marvin Bueno-Vélez, Carmen García-Martin, Roberto Muga, Daniel Fuster
Vitamin D Deficiency Is Associated with Advanced Liver Fibrosis and Impaired Fasting Glucose in Alcohol Use Disorder. Nutrients 16 (8) (2024)
Lamia Y Haque, Paola Zuluaga, Roberto Muga, Daniel Fuster
Treatment of alcohol use disorder in patients with alcohol-associated liver disease: Innovative approaches and a call to action. Addiction science & clinical practice 19 (1) (2024)
Lamia Y Haque, Paola Zuluaga, Roberto Muga, Daniel Fuster
Treatment of alcohol use disorder in patients with alcohol-associated liver disease: Innovative approaches and a call to action. Addiction science & clinical practice 19 (1) (2024)
Lamia Y Haque, Paola Zuluaga, Roberto Muga, Daniel Fuster
Treatment of alcohol use disorder in patients with alcohol-associated liver disease: Innovative approaches and a call to action. Addiction science & clinical practice 19 (1) (2024)
Paola Zuluaga, Daniel Fuster, Rafael Blanes, Anna Hernández-Rubio, Laia Miquel, Marta Torrens, Gabriel Rubio, Ferrán Bolao, Suthat Liangpunsakul, Enric Abellí-Deulofeu, Fernando Rodríguez de Fonseca, Roberto Muga, null null
Clinical features of individuals with laboratory values suggestive of advanced liver fibrosis when first treated for alcohol use disorder. Alcohol, clinical & experimental research 48 (7) (2024)
Paola Zuluaga, Daniel Fuster, Rafael Blanes, Anna Hernández-Rubio, Laia Miquel, Marta Torrens, Gabriel Rubio, Ferrán Bolao, Suthat Liangpunsakul, Enric Abellí-Deulofeu, Fernando Rodríguez de Fonseca, Roberto Muga, null null
Clinical features of individuals with laboratory values suggestive of advanced liver fibrosis when first treated for alcohol use disorder. Alcohol, clinical & experimental research (2024)
Lamia Y Haque, Paola Zuluaga, Roberto Muga, Daniel Fuster
Treatment of alcohol use disorder in patients with alcohol-associated liver disease: Innovative approaches and a call to action. Addiction science & clinical practice 19 (1) (2024)
Lamia Y Haque, Paola Zuluaga, Roberto Muga, Daniel Fuster
Treatment of alcohol use disorder in patients with alcohol-associated liver disease: Innovative approaches and a call to action. Addiction science & clinical practice 19 (1) (2024)
Daniel Fuster, Cristina Llorente, Xavier Garcia-Calvo, Ferran Bolao, Paola Zuluaga, Anna Hernández-Rubio, Julia Casado-Carbajo, Alba Leis, Roberto Muga
Fungal plasma biomarkers in patients admitted for hospital treatment of alcohol use disorder. Alcohol (Hanover, York County, Pa.) (2023)
Lourdes Poyatos, Adrián Torres, Esther Papaseit, Clara Pérez-Mañá, Olga Hladun, Melani Núñez-Montero, Georgina de la Rosa, Marta Torrens, Daniel Fuster, Roberto Muga, Magi Farré
Abuse Potential of Cathinones in Humans: A Systematic Review. Journal of clinical medicine 11 (4) (2022)
Nuria García-Marchena, Alberto Marcos, María Flores-Lopez, Mario Moreno-Fernández, Nerea Requena-Ocaña, Oscar Porras-Perales, Sandra Torres-Galván, Pedro Araos, Antonia Serrano, Roberto Muga, Juan Jesús Ruiz-Ruiz, Fernando Rodríguez de Fonseca, Emilio Ambrosio, Francisco Javier Pavón
Plasma Amino Acid Concentrations in Patients with Alcohol and/or Cocaine Use Disorders and Their Association with Psychiatric Comorbidity and Sex. Biomedicines 10 (5) (2022)
Paola Zuluaga, Aina Teniente-Serra, Daniel Fuster, Bibiana Quirant-Sánchez, Anna Hernández-Rubio, Eva M Martínez-Cáceres, Roberto Muga
Increased Natural Killer Cells Are Associated with Alcohol Liver Fibrosis and with T Cell and Cytotoxic Subpopulations Change. Journal of clinical medicine 11 (2) (2022)
Maria Alías-Ferri, Manuela Pellegrini, Emilia Marchei, Roberta Pacifici, Maria Concetta Rotolo, Simona Pichini, Clara Pérez-Mañá, Esther Papaseit, Roberto Muga, Francina Fonseca, Marta Torrens, Magi Farré
New Psychoactive Substances Consumption in Opioid-Use Disorder Patients. Biology 11 (5) (2022)
Daniel Fuster, Xavier Garcia-Calvo, Oriol Farré, Paola Zuluaga, Ferran Bolao, Alba Leis, Anna Hernández-Rubio, Inmaculada Rivas, Roberto Muga
Markers of Monocyte Activation, Inflammation, and Microbial Translocation Are Associated with Liver Fibrosis in Alcohol Use Disorder. Journal of clinical medicine 10 (16) (2021)
Esther Papaseit, Clara Pérez-Mañá, Marta Torrens, Adriana Farré, Lourdes Poyatos, Olga Hladun, Arantza Sanvisens, Roberto Muga, Magi Farré
MDMA interactions with pharmaceuticals and drugs of abuse. Expert opinion on drug metabolism & toxicology 16 (5) (2020)
Arantza Sanvisens, Irina Sanjeevan, Paola Zuluaga, Adrià Túnez, Antonio de Francisco, Esther Papaseit, Luis García-Eroles, Roberto Muga
Five-Year Incidence of Hospital-Based Emergencies Related to Acute Recreational Intoxication in Minors. Alcoholism, clinical and experimental research 43 (10) (2019)
Xavier García-Calvo, Ferran Bolao, Arantza Sanvisens, Paola Zuluaga, Jordi Tor, Roberto Muga, Daniel Fuster
Significance of Markers of Monocyte Activation (CD163 and sCD14) and Inflammation (IL-6) in Patients Admitted for Alcohol Use Disorder Treatment. Alcoholism, clinical and experimental research 44 (1) (2019)
Esther Papaseit, Marta Torrens, Clara Pérez-Mañá, Roberto Muga, Magi Farré
Key interindividual determinants in MDMA pharmacodynamics. Expert opinion on drug metabolism & toxicology 14 (2) (2018)
Gabriel Vallecillo, María José Robles, Marta Torrens, Pilar Samos, Albert Roquer, Paula K Martires, Arantza Sanvisens, Roberto Muga, Juan Pedro-Botet
Metabolic syndrome among individuals with heroin use disorders on methadone therapy: Prevalence, characteristics, and related factors. Substance abuse 39 (1) (2017)